Mycoplasma iowae in Turkeys: Embryo Mortality, Hatchery Infections, and Diagnostic Control

Etiology

Mycoplasma iowae is a member of the class Mollicutes, family Mycoplasmataceae. It is a small, pleomorphic, cell wall-deficient bacterium with a genome size of approximately 1.0 Mb. The organism requires sterols for growth and is fastidious in culture, necessitating enriched media such as Frey's medium supplemented with 10-15% swine serum. M. iowae is distinguished from other avian mycoplasmas by its serological specificity and unique biochemical profile: it ferments glucose but does not hydrolyze arginine or urea. Several serovars have been described, but the species is considered antigenically homogeneous for practical diagnostic purposes.

The pathogen is primarily associated with turkeys (Meleagris gallopavo), although it has been isolated from chickens and other galliform species. Unlike Mycoplasma gallisepticum and Mycoplasma synoviae, M. iowae does not typically cause respiratory disease; its primary pathogenic effects are on the reproductive system and developing embryo.

Epidemiology

M. iowae is transmitted both horizontally and vertically. Horizontal transmission occurs through direct contact, contaminated fomites, and possibly via the respiratory route, although respiratory signs are minimal. Vertical transmission is the most significant route for perpetuating infection in commercial turkey operations. Infected breeder hens shed the organism into the egg, leading to embryo infection and mortality. The organism can survive in the hatchery environment, including on eggshells, in incubators, and on hatchery equipment, facilitating lateral spread to newly hatched poults.

The prevalence of M. iowae in turkey flocks varies geographically. It is considered endemic in many turkey-producing regions, particularly where biosecurity measures are suboptimal. The infection is often subclinical in adult birds, making detection reliant on serological or molecular surveillance. Flocks with a history of poor hatchability and increased embryo mortality should be investigated for M. iowae.

Clinical Signs and Pathology

In Adult Turkeys

Adult breeder turkeys infected with M. iowae typically show no overt clinical signs. The infection is insidious, manifesting primarily as reduced egg production, decreased fertility, and increased embryo mortality. In some cases, mild airsacculitis or synovitis may be observed, but these are inconsistent findings.

In Embryos and Poults

The hallmark of M. iowae infection is turkey embryo death and hatchery mortality. Infected embryos die at various stages of incubation, with a peak often observed during the later stages (days 20-25). Gross lesions in dead embryos include:

• Subcutaneous edema
• Hemorrhages on the head and neck
• Enlarged, congested liver and spleen
• Airsacculitis
• Stunting and malformation

Poults that hatch may appear weak, have poor viability, and exhibit leg deformities or stunting. Mortality in the first week post-hatch can be elevated. The organism can be isolated from the yolk sac, liver, and respiratory tract of affected poults.

Pathology

Histopathological examination reveals necrotic and inflammatory changes in the liver, spleen, and bursa of Fabricius. Air sacs show thickening and infiltration with mononuclear cells. The yolk sac may contain caseous material. The pathogenesis involves colonization of the reproductive tract in hens, leading to infection of the developing egg. The organism multiplies in the embryo, causing systemic infection and death.

Diagnostics

Accurate diagnosis of M. iowae is essential for control. A combination of culture, serology, and molecular methods is recommended.

Culture

Isolation of M. iowae requires specialized media (e.g., Frey's medium) and incubation at 37°C in a 5-10% CO2 atmosphere. Colonies appear as typical "fried egg" morphology after 3-10 days. Samples include tracheal swabs, air sac lesions, yolk sac, and embryo tissues. Culture is definitive but slow and requires expertise.

Serology

Serological tests include the serum plate agglutination (SPA) test and enzyme-linked immunosorbent assay (ELISA). The SPA test is rapid but can yield false positives due to cross-reactions with other mycoplasmas. Commercial ELISA kits (generic, non-brand) are available and provide quantitative results. Seroconversion in breeder flocks indicates exposure, but serology alone cannot distinguish active infection from past exposure.

Molecular Detection

Polymerase chain reaction (PCR) is the preferred method for rapid and sensitive detection. Species-specific primers targeting the 16S rRNA gene or the gapA gene are used. Real-time PCR (qPCR) allows quantification and is useful for monitoring shedding. PCR can be performed on swabs, tissues, and egg contents. It is particularly valuable for detecting M. iowae in hatchery samples and for confirming vertical transmission.

Diagnostic Workflow

The following Mermaid diagram illustrates a recommended diagnostic algorithm for investigating Mycoplasma iowae turkey embryo death hatchery mortality in a breeder flock.

flowchart TD
    A[Poor hatchability / increased embryo mortality], > B{Collect samples}
    B, > C[Embryo tissues / yolk sac / dead-in-shell]
    B, > D[Tracheal swabs from breeders]
    B, > E[Environmental swabs from hatchery]
    C, > F[PCR for M. iowae]
    D, > F
    E, > F
    F, > G{Result}
    G, >|Positive| H[Confirm by culture or sequencing]
    G, >|Negative| I[Consider other causes: Mycoplasma meleagridis, Salmonella, nutritional]
    H, > J[Implement control measures]
    J, > K[Biosecurity, antibiotic treatment, flock depopulation]
    I, > L[Further diagnostic workup]

Differential Diagnosis

Other causes of embryo mortality and hatchery problems in turkeys include:

• Mycoplasma meleagridis (airsacculitis, leg deformities) – see Mycoplasma meleagridis: Turkey Airsacculitis and Leg Deformities – Hatchery Transmission and Control
• Mycoplasma synoviae (eggshell apex abnormalities, synovitis) – see Mycoplasma synoviae: Infectious Synovitis in Chickens and Turkeys – Eggshell Apex Abnormalities and Control
• Salmonella spp. – see Salmonella in Chickens: Clinical Signs, Zoonotic Risks, and Diagnostic Differentiation from Other Enteric Pathogens
• Escherichia coli – see Escherichia coli in Chickens and Poultry Products: Bacterial Pathogenesis, Contamination Routes, Clinical Signs in Flocks, and Public Health Risks
• Histomonas meleagridis – see Histomonas meleagridis: Blackhead Disease in Turkeys – Hepatic and Cecal Pathology, Diagnosis, and Control
• Nutritional deficiencies (e.g., vitamin E, selenium)
• Management factors (incubation temperature, humidity)

Treatment and Control

Antimicrobial Therapy

M. iowae is susceptible to antibiotics that target protein synthesis, such as tylosin, tiamulin, and enrofloxacin. However, treatment of breeder flocks is often ineffective in eliminating the organism due to its intracellular location and the difficulty of achieving therapeutic concentrations in the reproductive tract. In ovo injection of antibiotics (e.g., gentamicin) has been used but is not a reliable control measure. Antimicrobial resistance is a growing concern, and sensitivity testing should guide therapy where possible.

Biosecurity and Management

Control of M. iowae relies on strict biosecurity and hatchery hygiene. Key measures include:

• Hatchery sanitation: Regular cleaning and disinfection of incubators, hatchers, and egg handling equipment. Formaldehyde fumigation or hydrogen peroxide vapor can reduce environmental contamination.
• Egg hygiene: Use of clean, sanitized eggs from known negative flocks. Avoid pooling eggs from multiple sources.
• Flock monitoring: Regular serological and PCR testing of breeder flocks to detect infection early. Positive flocks should be removed from the breeding program.
• All-in/all-out management: Depopulation of infected flocks followed by thorough cleaning and downtime before restocking.
• Vaccination: No commercial vaccine is widely available for M. iowae. Autogenous bacterins have been used experimentally but with variable efficacy.

Eradication

Eradication of M. iowae from a turkey operation is challenging but achievable through a combination of testing, culling, and biosecurity. The National Poultry Improvement Plan (NPIP) in the United States includes M. iowae as a monitored pathogen. Flocks can be certified as M. iowae-free through regular testing.

Conclusion

Mycoplasma iowae remains a significant cause of embryo mortality and hatchery losses in turkeys. Its ability to transmit vertically and persist in the hatchery environment makes control difficult. Accurate diagnosis using PCR and serology, combined with rigorous biosecurity, is essential for reducing economic losses. Ongoing surveillance and research into effective vaccines are needed to improve management of this pathogen.

References

1. World Organisation for Animal Health (WOAH). Manual of Diagnostic Tests and Vaccines for Terrestrial Animals. Chapter 3.3.5: Avian Mycoplasmosis (Mycoplasma gallisepticum, M. synoviae, M. meleagridis, M. iowae). Paris: WOAH.
2. Ley DH, Yoder HW Jr. Mycoplasma iowae infection. In: Swayne DE, editor. Diseases of Poultry. 14th ed. Ames: Wiley-Blackwell; 2020. p. 907-915.
3. Kleven SH. Mycoplasmas in poultry. In: Whitthear KG, Browning GF, editors. Mycoplasmas: Molecular Biology, Pathogenicity and Strategies for Control. Norfolk: Horizon Bioscience; 2005. p. 215-240.